Skip to main content
. 2021 Oct 25;54(3):803–816. doi: 10.4143/crt.2021.764

Fig. 2.

Fig. 2

Network plot: overall survival (A) and progression-free survival (B). The size of each dot represents the number of patients receiving the corresponding intervention. The width of each line represents the number of corresponding comparison studies. Atezo+Beva+Chemo, atezolizumab+bevacizumab+chemotherapy; Atezo+Chemo, atezolizumab+chemotherapy; Beva+Chemo, bevacizumab+chemotherapy; Chemo, chemotherapy; Nivo, nivolumab; Nivo+Ipi, nivolumab+ipilimumab; Pembro+Chemo, pembrolizumab+chemotherapy.